387 related articles for article (PubMed ID: 20945414)
1. Inhibition of all-trans-retinoic acid-induced proteasome activation potentiates the differentiating effect of retinoid in acute myeloid leukemia cells.
Fang Y; Zhou X; Lin M; Ying M; Luo P; Zhu D; Lou J; Yang B; He Q
Mol Carcinog; 2011 Jan; 50(1):24-35. PubMed ID: 20945414
[TBL] [Abstract][Full Text] [Related]
2. Bortezomib sensitizes human acute myeloid leukemia cells to all-trans-retinoic acid-induced differentiation by modifying the RARα/STAT1 axis.
Ying M; Zhou X; Zhong L; Lin N; Jing H; Luo P; Yang X; Song H; Yang B; He Q
Mol Cancer Ther; 2013 Feb; 12(2):195-206. PubMed ID: 23243061
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of mammalian target of rapamycin signaling potentiates the effects of all-trans retinoic acid to induce growth arrest and differentiation of human acute myelogenous leukemia cells.
Nishioka C; Ikezoe T; Yang J; Gery S; Koeffler HP; Yokoyama A
Int J Cancer; 2009 Oct; 125(7):1710-20. PubMed ID: 19507250
[TBL] [Abstract][Full Text] [Related]
4. GSK3 is a regulator of RAR-mediated differentiation.
Gupta K; Gulen F; Sun L; Aguilera R; Chakrabarti A; Kiselar J; Agarwal MK; Wald DN
Leukemia; 2012 Jun; 26(6):1277-85. PubMed ID: 22222598
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of caffeic acid phenethyl ester on all-trans retinoic acid-induced differentiation in human leukemia HL-60 cells.
Kuo HC; Kuo WH; Lee YJ; Wang CJ; Tseng TH
Toxicol Appl Pharmacol; 2006 Oct; 216(1):80-8. PubMed ID: 16766008
[TBL] [Abstract][Full Text] [Related]
6. Induction of a functional vitamin D receptor in all-trans-retinoic acid-induced monocytic differentiation of M2-type leukemic blast cells.
Manfredini R; Trevisan F; Grande A; Tagliafico E; Montanari M; Lemoli R; Visani G; Tura S; Ferrari S; Ferrari S
Cancer Res; 1999 Aug; 59(15):3803-11. PubMed ID: 10446999
[TBL] [Abstract][Full Text] [Related]
7. Expression, protein stability and transcriptional activity of retinoic acid receptors are affected by microtubules interfering agents and all-trans-retinoic acid in primary rat hepatocytes.
Dvorák Z; Vrzal R; Ulrichová J; Macejová D; Ondková S; Brtko J
Mol Cell Endocrinol; 2007 Mar; 267(1-2):89-96. PubMed ID: 17291686
[TBL] [Abstract][Full Text] [Related]
8. The ubiquitin-proteasome pathway plays essential roles in ATRA-induced leukemia cells G0/G1 phase arrest and transition into granulocytic differentiation.
Fang Y; Zhou X; Lin M; Jing H; Zhong L; Ying M; Luo P; Yang B; He Q
Cancer Biol Ther; 2010 Dec; 10(11):1157-67. PubMed ID: 20935519
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine kinase inhibitor STI571 potentiates the pharmacologic activity of retinoic acid in acute promyelocytic leukemia cells: effects on the degradation of RARalpha and PML-RARalpha.
Gianni' M; Kalaç Y; Ponzanelli I; Rambaldi A; Terao M; Garattini E
Blood; 2001 May; 97(10):3234-43. PubMed ID: 11342454
[TBL] [Abstract][Full Text] [Related]
10. p38αMAPK interacts with and inhibits RARα: suppression of the kinase enhances the therapeutic activity of retinoids in acute myeloid leukemia cells.
Gianni M; Peviani M; Bruck N; Rambaldi A; Borleri G; Terao M; Kurosaki M; Paroni G; Rochette-Egly C; Garattini E
Leukemia; 2012 Aug; 26(8):1850-61. PubMed ID: 22354283
[TBL] [Abstract][Full Text] [Related]
11. Granulocytic differentiation of human NB4 promyelocytic leukemia cells induced by all-trans retinoic acid metabolites.
Idres N; Benoît G; Flexor MA; Lanotte M; Chabot GG
Cancer Res; 2001 Jan; 61(2):700-5. PubMed ID: 11212271
[TBL] [Abstract][Full Text] [Related]
12. Small ubiquitin-related modifier-1 modification regulates all-trans-retinoic acid-induced differentiation via stabilization of retinoic acid receptor α.
Zhou Q; Zhang L; Chen Z; Zhao P; Ma Y; Yang B; He Q; Ying M
FEBS J; 2014 Jul; 281(13):3032-47. PubMed ID: 24819975
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity of MLL-rearranged AML cells to all-trans retinoic acid is associated with the level of H3K4me2 in the RARα promoter region.
Sakamoto K; Imamura T; Yano M; Yoshida H; Fujiki A; Hirashima Y; Hosoi H
Blood Cancer J; 2014 Apr; 4(4):e205. PubMed ID: 24769646
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of SALL4 Protein Enhances All-trans Retinoic Acid-induced Cellular Differentiation in Acute Myeloid Leukemia Cells.
Liu L; Liu L; Leung LH; Cooney AJ; Chen C; Rosengart TK; Ma Y; Yang J
J Biol Chem; 2015 Apr; 290(17):10599-609. PubMed ID: 25737450
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitinated or sumoylated retinoic acid receptor alpha determines its characteristic and interacting model with retinoid X receptor alpha in gastric and breast cancer cells.
Wu Q; Lin XF; Ye XF; Zhang B; Xie Z; Su WJ
J Mol Endocrinol; 2004 Jun; 32(3):595-613. PubMed ID: 15171703
[TBL] [Abstract][Full Text] [Related]
16. A functionally active RARalpha nuclear receptor is expressed in retinoic acid non responsive early myeloblastic cell lines.
Grande A; Montanari M; Manfredini R; Tagliafico E; Zanocco-Marani T; Trevisan F; Ligabue G; Siena M; Ferrari S; Ferrari S
Cell Death Differ; 2001 Jan; 8(1):70-82. PubMed ID: 11313705
[TBL] [Abstract][Full Text] [Related]
17. RARγ-C-Fos-PPARγ2 signaling rather than ROS generation is critical for all-trans retinoic acid-inhibited adipocyte differentiation.
Wang X; Yang P; Liu J; Wu H; Yu W; Zhang T; Fu H; Liu Y; Hai C
Biochimie; 2014 Nov; 106():121-30. PubMed ID: 25173565
[TBL] [Abstract][Full Text] [Related]
18. All-trans retinoic acid inhibits tumor growth of human osteosarcoma by activating Smad signaling-induced osteogenic differentiation.
Yang QJ; Zhou LY; Mu YQ; Zhou QX; Luo JY; Cheng L; Deng ZL; He TC; Haydon RC; He BC
Int J Oncol; 2012 Jul; 41(1):153-60. PubMed ID: 22485251
[TBL] [Abstract][Full Text] [Related]
19. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization.
Nason-Burchenal K; Maerz W; Albanell J; Allopenna J; Martin P; Moore MA; Dmitrovsky E
Differentiation; 1997 Aug; 61(5):321-31. PubMed ID: 9342843
[TBL] [Abstract][Full Text] [Related]
20. Synergistic antitumor activity of lapatinib and retinoids on a novel subtype of breast cancer with coamplification of ERBB2 and RARA.
Paroni G; Fratelli M; Gardini G; Bassano C; Flora M; Zanetti A; Guarnaccia V; Ubezio P; Centritto F; Terao M; Garattini E
Oncogene; 2012 Jul; 31(29):3431-43. PubMed ID: 22056878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
